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Abstract
Purpose CKD patients after kidney transplantation continue to suffer from elevated CV events which may be related to 
low vitamin D and its adverse impact on vascular function. The prevalence of vitamin D deficiency in North Indian kidney 
transplantation patients and its impact on vascular and bone biomarkers is unknown which this study investigated.
Methods Non-diabetic, stable, > 6 months post-kidney transplantation patients, not on vitamin D supplementation, were 
recruited after informed consent. Data on demographics, anthropometrics and treatment were collected. Blood samples were 
stored at − 80 °C until analysis for bone and endothelial cell biomarkers using standard ELISA techniques.
Results The clinical characteristics were: age 37.4 ± 9.9 years, 80% men, 27% ex-smokers, BP 125.5 ± 15.7/78.6 ± 9.7 mmHg, 
cholesterol 172.0 ± 47.8 mg/dL, hemoglobin 12.6 ± 2.3 g/dL, calcium 9.5 ± 0.6 mg/d and iPTH 58.4 ± 32.9 ng/mL and vitamin 
D 36.5 ± 39.8 nmol/L. Patients with vitamin D < 37.5 nmol/L (66%) had similar age, serum creatinine, serum phosphate, 
iPTH, blood pressure but lower calcium (9.3 ± 0.7 vs. 9.6 ± 0.5 mg/dL; p = 0.024), lower FGF23 (median 18.8 vs. 80.0 pg/mL; 
p = 0.013) and higher E-selectin (15.8 ± 7.9 vs. 13.0 ± 5.5 ng/mL; p = 0.047). On Univariate analysis, E-selectin (r = − 0.292; 
p = 0.005), FGF23 (r = 0.217; p = 0.036) and calcium (r = 0.238; p = 0.022) were significantly correlated with vitamin D lev-
els. On stepwise multiple regression analysis, only E-selectin was associated with vitamin D levels (β = − 0.324; p = 0.002).
Conclusion Vitamin D deficiency was common in kidney transplant recipients in North India, associated with low FGF23 
and high E-selectin. These findings suggest further investigations to assess the role of vitamin D deficiency-associated 
endothelial dysfunction, its implications and reversibility in kidney transplantation recipients.
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Background
The high mortality due to cardiovascular events in chronic 
kidney disease (CKD) patients is not fully explained by 
traditional risk factors, leading to exploration of the con-
tribution of non-traditional risk factors such as vitamin D 
deficiency. Vitamin D deficiency has been associated with 
endothelial dysfunction [1] and atherosclerosis in general 
population and in subjects with CKD [2, 3]. Cardiovascular 
events are the commonest cause of mortality post-kidney 
transplantation, fifty-fold higher than general population [4].
Fibroblast growth factor (FGF) 23, a phosphaturic hor-
mone, is affected by vitamin D and associated with CV risk 
in CKD [5, 6]. FGF23 reduces vitamin D synthesis and 
increases serum PTH [7]. Serum FGF23 level is increased 
in hemodialysis patients and is associated with mortality [8]. 
High FGF23 is also associated with cardiovascular mortality 
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in CKD patients [9]. Some recent studies have reported 
strong association of FGF23 with endothelial dysfunction 
and cardiovascular risk in CKD subjects [6, 10]. FGF23 
declines post-kidney transplantation, but the relationship 
with vitamin D levels has not been investigated [11].
The relationship of vitamin D deficiency with endothelial 
dysfunction has been investigated in Indian CKD patients 
but not in kidney transplantation recipients, who are rela-
tively younger and recipient of live donor kidneys. We have 
previously demonstrated poor endothelial function in post-
transplant and CKD subjects [12] which improves with vita-
min D supplementation in CKD patients [13, 14]. In this 
study, we investigated the relationship of vitamin D defi-
ciency with FGF23 and biomarkers of endothelial dysfunc-
tion (E-selectin) in North Indian kidney transplant patients.
Materials and methods
This cross-sectional study was carried out between Decem-
ber 2013 and December 2014 at the Postgraduate Institute 
of Medical Education and Research, Chandigarh, India. 
Adult (18–70 years), clinically stable kidney transplant 
recipients who had received their grafts at least 6 months 
ago were enrolled. Patents with abnormal renal function 
(serum creatinine > 1.5 mg/dL), history of hospitalization 
in last 6 months, those on any vitamin D supplementation, 
history of rejection, recurrent nephrotic syndrome, evidence 
of chronic diseases like diabetes mellitus, heart failure, liver 
disease, recent infections and significant proteinuria were 
excluded. All clinical and demographic parameters were 
recorded for each patient.
Venous blood sample was collected in serum separat-
ing tube, centrifuged at 2000 rpm for 25 min and separated 
serum stored at − 80 °C for biomarker analysis.
Biomarker assays
Serum samples were used in duplicates to analyze all bio-
markers. Total 25 (OH) vitamin D concentration was meas-
ured using a commercially available enzyme immunoassay 
(EIA) kit (IDS Laboratory, UK). The sensitivity of this assay 
was 5 nmol/L. The intra- and inter-assay coefficients of vari-
ation of this assay were 6.7% and 8.7%, respectively. FGF23 
concentrations were measured by a commercial ELISA kit 
(Immutopics, Inc., San Clemente, CA, USA). The sensitivity 
of the assay was 1.0 pg/mL, intra-assay coefficient of vari-
ation was 2.6–4.4%, and inter-assay coefficient of variation 
was 6.1–6.5%. E-selectin was measured using ELISA (Inv-
itrogen, Frederick, MD). The limit of detection of E-selec-
tin was determined to be less than 0.33 ng/mL (mean of 6 
independent assays). The intra-assay and inter-assay coef-
ficient of variation is 5.4% and 6.0%, respectively. Intact 
PTH was measured using Ray Bio EIA Kit (Ray Biotech, 
Inc. Norcross, GA, USA). All samples were diluted 4 times 
before the assay. The minimum detectable concentration 
was 1.27 pg/mL. The intra- and inter-assay coefficients of 
variation of this assay were < 10% and < 15%, respectively. 
Serum calcium and phosphorus were measured on the Cobas 
C111 automated analyzer (Roche Diagnostics, Indianapolis, 
IN, USA).
Statistical analysis
Data are presented as mean ± SD or median and interquar-
tile range. All data were tested for normality of distribu-
tion. Continuous variables were compared with independ-
ent samples Student’s t test if normally distributed, or 
with Mann–Whitney U test. Correlations were tested with 
Spearman’s rank correlation coefficient. Stepwise multiple 
regression analysis was performed to test independent asso-
ciation of vitamin D with other parameters. Two-tailed p 
value < 0.05 was considered as statistically significant. All 
analyses were conducted using the SPSS software version 
24.0 (IBM).
Results
A total of 93 patients were enrolled. The mean age of the 
patients was 37.4 ± 9.9 years. The study included 18 (19.4%) 
female and 75 (80.6%) male patients. The cause of end stage 
renal disease was chronic glomerulonephritis, chronic inter-
stitial nephritis and autosomal dominant polycystic kidney 
disease in 44 (47.3%), 7 (7.5%) and 5 (5.4%), respectively, 
and the basic disease was not known in 37 (39.8%). Twenty-
seven percentage of the study participants were ex-smokers. 
The mean body mass index was 20.8 ± 3.3 kg/m2. The mean 
serum creatinine was 1.3 ± 0.3 mg/dL. The mean total cho-
lesterol was 172.0 ± 47.8 mg/dL (Table 1).
The mean serum calcium and phosphorus were 9.5 ± 0.6 
and 3.3 ± 0.8 mg/dL, respectively. The mean serum 25 (OH) 
vitamin D was 36.5 ± 39.8 nmol/L. The mean FGF23, iPTH 
and E-selectin were 75.3 ± 85.3 pg/mL, 58.4 ± 32.9 pg/
mL and 14.8 ± 7.3 ng/mL, respectively. On comparing 25 
(OH) vitamin D deficient (< 37.5 nmol/L) and non-deficient 
(≥ 37.5 nmol/L) patients, those with 25 OH vitamin D defi-
ciency had higher E-selectin (p = 0.047) and lower FGF23 
(p = 0.013) compared to non-deficient patients (Table 2; 
Fig. 1a, b). There were no significant differences in the other 
parameters (Table 2). On univariate analysis, E-selectin 
(r = − 0.292, p = 0.005), FGF23 (r = 0.217, p = 0.036) and 
calcium (r = 0.238, p = 0.022) significantly correlated with 
vitamin D levels. On stepwise multiple regression analy-
sis, only E-selectin was associated with vitamin D levels 
(β = − 0.324, p = 0.002).
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Patients with E-selectin levels in their third tertile had 
lower 25-OH vitamin D compared to those in the first ter-
tile. There was no difference in FGF-23, iPTH and other 
clinical/ biochemical parameters between various tertiles 
(Table 3).
Discussion
In the present cross-sectional study, we correlated marker 
of endothelial dysfunction (E-selectin), FGF23 and iPTH 
with serum 25 (OH) vitamin D levels in renal transplant 
recipients with stable graft function. Salient findings in the 
study were increased levels of E-selectin and lower FGF 23 
in patients with vitamin D deficiency.
Renal dysfunction is associated with endothelial dysfunc-
tion, which is a cause of premature atherosclerosis in the 
patients with CKD [1, 15]. Renal transplantation is the best 
treatment for end stage renal disease; however, even success-
ful renal transplantation does not reverse all cardiovascular 
dysfunction. Low levels of vitamin D are associated with 
major cardiovascular events, e.g., myocardial infraction, 
stroke and mortality related to cardiovascular and cerebro-
vascular diseases [16–19]. Multiple cross-sectional studies 
have reported association of vitamin D with endothelial dys-
function [1, 20]. Yildirim et al. [21] evaluated endothelial 
dysfunction in 109 renal transplant recipients, all the patients 
underwent flow mediated dilatation (FMD), serum 25-OH 
vitamin D and FGF 23 level. Vitamin D and FGF-23 levels 
were compared between patients with normal and abnormal 
endothelial functions. Seventy-two percent of the transplant 
recipients had endothelial dysfunction, and 80% had vitamin 
D deficiency. Patients with abnormal endothelial function 
had lower vitamin D levels compared to patients with normal 
endothelial function. FGF23 level was numerically higher in 
patients with abnormal endothelial compared to those with 
normal endothelial function, but this difference did not reach 
Table 1  Demographic, detailed clinical and biochemical characteris-
tic and serum biomarkers in study subjects
Data presented as mean ± standard deviation and number (percentage)
FGF23 fibroblast growth factor 23, iPTH intact parathyroid hormone
Parameters N = 93
Age (years) 37.4 ± 9.9
Male/female 75/18
Ex-smoker 25 (27%)
Body mass index (kg/m2) 20.8 ± 3.3
Systolic blood pressure (mmHg) 125.3 ± 15.2
Diastolic blood pressure (mmHg) 78.6 ± 9.7
Creatinine (mg/dL) 1.3 ± 0.3
Hemoglobin (mg/dL) 12.6 ± 2.3
Urea (mg/dL) 39.5 ± 15.3
Fasting blood sugar (mg/dL) 90.4 ± 17.4
Total cholesterol (mg/dL) 172.0 ± 47.8
Calcium (mg/dL) 9.5 ± 0.6
Inorganic phosphorus (mg/dL) 3.3 ± 0.8
25 (OH) vitamin D (nmol/L) 36.5 ± 39.8
E-selectin (ng/mL) 14.8 ± 7.3
FGF23 (pg/mL) 75.3 ± 85.3
iPTH (pg/mL) 58.4 ± 32.9
Table 2  Patient characteristic 
according to vitamin D category
Data presented as mean ± standard deviation except for *FGF23 which is presented as median (25th–75th 
percentile)
FGF23 fibroblast growth factor 23, iPTH intact parathyroid hormone
25(OH) Vit 
D ≥ 37.5 nmol/L (N = 32)
25(OH) Vit 
D < 37.5 nmol/L (N = 61)
p value
Age (years) 38.5 ± 12.2 36.9 ± 8.5 0.504
Body mass index (kg/m2) 20.8 ± 3.0 20.9 ± 3.5 0.888
Systolic blood pressure (mmHg) 123.1 ± 14.8 126.5 ± 15.3 0.301
Diastolic blood pressure (mmHg) 78.3 ± 9.8 78.8 ± 9.6 0.808
Hemoglobin (mg/dL) 12.4 ± 2.2 12.8 ± 2.3 0.515
Serum creatinine 1.3 ± 0.3 1.2 ± 0.4 0.165
Serum urea (mg/dL) 39.7 ± 12.0 39.4 ± 17.1 0.941
Total cholesterol (mg/dL) 180.0 ± 57.6 168.1 ± 42.6 0.465
Calcium (mg/dL) 9.6 ± 0.5 9.3 ± 0.7 0.024
Inorganic phosphorus (mg/dL) 3.3 ± 0.57 3.3 ± 0.93 0.937
25 (OH)D (nmol/L) 53.1 ± 11.7 22.4 ± 7.2 < 0.0001
E-selectin (ng/mL) 13.0 ± 5.5 15.8 ± 7.9 0.047
FGF23 (pg/mL)* 80.0 (17.8–185.4) 18.8 (17.4–95.6) 0.013
iPTH (pg/mL) 53.3 ± 35.0 61.1 ± 31.8 0.294
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statistical significance. On a stepwise multivariate regression 
analysis, only 25(OH) vitamin D independently predicted 
endothelial dysfunction. Malyszko et al. [22] evaluated the 
relation of FGF23 and Klotho in 84 stable renal transplant 
recipients with endothelial function markers; von willebrand 
factor (vWF), intercellular adhesion molecule (ICAM), 
vascular cell adhesion molecule (VCAM) and interleukin-6 
(IL-6). The authors observed higher levels of FGF-23 and 
lower Klotho levels in renal transplant recipients compared 
to healthy controls. FGF23 correlated with copeptin, IL-6, 
VCAM, platelet count, time after transplantation, vWF and 
serum calcium levels. The observation let to conclusion of 
disturbed FGF23-Klotho system in patients with endothelial 
injury. Higher levels of E-selectin in patients with vitamin D 
deficiency observed in the present study suggest significant 
association of endothelial dysfunction with vitamin D levels 
and are similar to that reported by Yildirim et al. [21].
In our study, we found the significant inverse associa-
tion of E-selectin with 25(OH) D level which remained 
significant in multiple regression analysis. This indicates 
that 25(OH) D may predict endothelial dysfunction in renal 
transplant patients. This study is in agreement with the study 
of Yildrim et al. [21] which show the endothelial dysfunction 
in subjects with low 25(OH)D. We did not find any associa-
tion of FGF23 with endothelial function which, again, was 
in agreement with the study of Yildrim et al. [21]. No study 
has previously demonstrated a relationship of FGF 23 with 
endothelial dysfunction in kidney transplantation patients. 
However, such relation is known in general population and 
CKD patients [10, 23]. In a recent study, FGF23 was inde-
pendently associated with cardiovascular mortality post-
renal transplantation and it remained significant even after 
adjustment for markers of mineral metabolism and other 
Fig. 1  Bar graph showing the serum level of E-selectin and FGF23 
in renal transplant recipients with vitamin D level < 37.5 nmol/L and 
≥ 37.5 nmol/L. a E-selectin was significantly low, and b FGF-23 was 
high in renal transplant recipients with vitamin D ≥ 37.5  nmol/L as 
compared to vitamin D level < 37.5 nmol/L
Table 3  Patient characteristic 
according to E-selectin tertiles
Data presented as mean ± SD except for *FGF23 which is presented as median (25th–75th percentile)
FGF23 fibroblast growth factor 23, iPTH intact parathyroid hormone
a p value < 0.05, compared to tertile 3
b p value < 0.05. compared to tertile 1
Tertile 1 Tertile 2 Tertile 3
Age (years) 38.6 ± 10.7 36.9 ± 10.4 36.8 ± 8.7
Body mass index (kg/m2) 20.4 ± 3.6 19.9 ± 3.0a 22.1 ± 2.9b
Hemoglobin (mg/dL) 12.6 ± 2.3 12.1 ± 2.4 13.2 ± 1.9
Serum creatinine 1.3 ± 0.4 1.3 ± 0.3 1.2 ± 0.4
Serum urea (mg/dL) 37.9 ± 14.1 42.1 ± 15.0 38.2 ± 17.1
Total cholesterol (mg/dL) 170.0 ± 41.0 178.7 ± 61.8 167.7 ± 41.7
Calcium (mg/dL) 9.5 ± 0.6 9.4 ± 0.7 9.4 ± 0.6
Inorganic phosphorus (mg/dL) 3.3 ± 1.1 3.3 ± 0.6 3.2 ± 0.7
25 (OH)D (nmol/L) 36.6 ± 18.7 34.8 ± 15.9a 27.08 ± 15.3b
E selectine (ng/mL) 8.0 ± 1.7 13.2 ± 2.0 23.2 ± 5.8
FGF23 (pg/mL)* 72.8 (17.7–145.5) 19.3 (17.7–116.3) 19.5 (17.0–94.8)
iPTH (pg/mL) 61.4 ± 33.8 61.7 ± 33.4 52.3 ± 31.8
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cardiovascular risk factors, emphasising the possible role of 
FGF-23 [24]. A case-control study in general population by 
Tarcin et al. [25] reported that subjects with vitamin D defi-
ciency had a lower FMD as compared to the subjects with 
sufficient vitamin D levels, and London et al. [20] showed 
a correlation between 25(OH)D levels and FMD in patients 
on dialysis. Observational studies indicate that vitamin D is 
an independent predictor of endothelial function (FMD) in 
non-dialysis CKD patients; all suggest an active impact of 
vitamin D on vascular function in non-transplant CKD and 
general population [1, 26].
The limitations of the study are its small sample size and 
cross-sectional design. The study shows only relationship 
of 25(OH)D, FGF23 and E-selectin and does not provide 
cause and association analysis. However, it is the first study 
in North Indian kidney transplantation population which 
evaluates vitamin D deficiency, biomarker of endothelial 
function and FGF23.
In conclusion, this study shows that vitamin D deficiency 
is associated with markers endothelial dysfunction and 
increased FGF23 in renal transplant subjects. Further, stud-
ies are required to confirm the association in a larger cohort 
and clinical trials to investigate whether supplementation 
of vitamin D improves these parameters in renal transplant 
patients.
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